Literature DB >> 22378475

Age-graded reductions in quadriceps muscle strength and peak aerobic capacity in COPD.

Martijn A Spruit1, Frits M E Franssen, Erica P A Rutten, Scott S Wagers, Emiel F M Wouters.   

Abstract

BACKGROUND: Reductions in quadriceps strength and peak aerobic capacity (VO2) in patients with chronic obstructive pulmonary disease (COPD) have been studied in relatively small samples over a short period. Moreover, results were not corrected for confounding variables, such as lean muscle mass, gender, and gas transfer capacity of the lungs.
OBJECTIVES: To compare quadriceps muscle strength and peak V.O2 in women and men while stratifying for age and gas transfer capacity. We then corrected for lower-limb lean muscle mass to see whether and to what extent the age-graded reduction remained evident.
METHODS: Retrospectively, data of 374 women and 593 men with COPD were analyzed: lung function, current drug therapy, quadriceps strength, peak V.O2, lower-limb lean muscle mass, and gas transfer capacity.
RESULTS: Quadriceps strength and peak V.O2 were lower in older women and men with a gas transfer capacity of <50% predicted, also after adjustment for lower-limb lean muscle mass. Moreover, quadriceps strength and peak V.O2 were lower in older women and men with a gas transfer capacity of <50% predicted, also after adjustment for lower-limb lean muscle mass. Moreover, quadriceps strength and peak V.O2 were related to age in COPD, particularly in women and men with a gas transfer capacity of >50% predicted. Yet, counter to our hypothesis, lower-limb lean muscle mass did not show an age-graded reduction and, in turn, could not account for the relationship of age with quadriceps strength and peak V.O2.
CONCLUSIONS: It is apparent that there is an age-graded reduction in skeletal muscle function in patients with COPD. Therefore, prevention of an age-graded decline in quadriceps muscle strength and peak V.O2 may need to become an outcome of pulmonary rehabilitation of patients with COPD.

Entities:  

Mesh:

Year:  2012        PMID: 22378475     DOI: 10.1590/s1413-35552012005000011

Source DB:  PubMed          Journal:  Rev Bras Fisioter


  8 in total

1.  Resistance training as a preconditioning strategy for enhancing aerobic exercise training outcomes in COPD.

Authors:  Margaret K Covey; Eileen G Collins; Sandra I Reynertson; Daniel F Dilling
Journal:  Respir Med       Date:  2014-06-11       Impact factor: 3.415

2.  Measurement properties of the Timed Up & Go test in patients with COPD.

Authors:  Rafael Mesquita; Sarah Wilke; Dionne E Smid; Daisy Ja Janssen; Frits Me Franssen; Vanessa S Probst; Emiel Fm Wouters; Jean Wm Muris; Fabio Pitta; Martijn A Spruit
Journal:  Chron Respir Dis       Date:  2016-07-08       Impact factor: 2.444

3.  Effect of modified Total Body Recumbent Stepper training on exercise capacity and thioredoxin in COPD: a randomized clinical trial.

Authors:  Wentao Duan; Dan Zeng; Jin Huang; Jing Gu; San Li; Wei Zhou; Jinling Ma; Yan Jiang; Liming Zhu; Xudong Xiang; Aiguo Dai
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

4.  Effects of body mass index on task-related oxygen uptake and dyspnea during activities of daily life in COPD.

Authors:  Anouk W Vaes; Frits M E Franssen; Kenneth Meijer; Martijn W J Cuijpers; Emiel F M Wouters; Erica P A Rutten; Martijn A Spruit
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

Review 5.  Musculoskeletal disorders in chronic obstructive pulmonary disease.

Authors:  Nele Cielen; Karen Maes; Ghislaine Gayan-Ramirez
Journal:  Biomed Res Int       Date:  2014-03-25       Impact factor: 3.411

6.  Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD.

Authors:  Vasileios Andrianopoulos; Scott S Wagers; Miriam T J Groenen; Lowie E Vanfleteren; Frits M E Franssen; Frank W J M Smeenk; Ioannis Vogiatzis; Emiel F M Wouters; Martijn A Spruit
Journal:  BMC Pulm Med       Date:  2014-05-31       Impact factor: 3.317

7.  Validity of the six-minute step test of free cadence in patients with chronic obstructive pulmonary disease.

Authors:  Bruna V Pessoa; Juliano F Arcuri; Ivana G Labadessa; Joyce N F Costa; Anna C Sentanin; Valéria A Pires Di Lorenzo
Journal:  Braz J Phys Ther       Date:  2014 May-Jun       Impact factor: 3.377

8.  Aging and extrapulmonary effects of chronic obstructive pulmonary disease.

Authors:  Emanuela Tudorache; Ariadna Petronela Fildan; Mirela Frandes; Elena Dantes; Doina Ecaterina Tofolean
Journal:  Clin Interv Aging       Date:  2017-08-16       Impact factor: 4.458

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.